Minerva Surgical (UTRS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends UTRS vs. MOTS, NYXH, STVN, SYK, BSX, MMM, BDX, RMD, DXCM, and WSTShould you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Motus GI (MOTS), Nyxoah (NYXH), Stevanato Group (STVN), Stryker (SYK), Boston Scientific (BSX), 3M (MMM), Becton, Dickinson and Company (BDX), ResMed (RMD), DexCom (DXCM), and West Pharmaceutical Services (WST). These companies are all part of the "surgical & medical instruments" industry. Minerva Surgical vs. Motus GI Nyxoah Stevanato Group Stryker Boston Scientific 3M Becton, Dickinson and Company ResMed DexCom West Pharmaceutical Services Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends. Is UTRS or MOTS more profitable? Minerva Surgical has a net margin of 0.00% compared to Motus GI's net margin of -3,239.75%. Minerva Surgical's return on equity of 0.00% beat Motus GI's return on equity.Company Net Margins Return on Equity Return on Assets Minerva SurgicalN/A N/A N/A Motus GI -3,239.75%-1,731.08%-115.99% Does the MarketBeat Community believe in UTRS or MOTS? Motus GI received 156 more outperform votes than Minerva Surgical when rated by MarketBeat users. Likewise, 65.73% of users gave Motus GI an outperform vote while only 41.18% of users gave Minerva Surgical an outperform vote. CompanyUnderperformOutperformMinerva SurgicalOutperform Votes741.18% Underperform Votes1058.82% Motus GIOutperform Votes16365.73% Underperform Votes8534.27% Which has more volatility & risk, UTRS or MOTS? Minerva Surgical has a beta of 3.96, indicating that its stock price is 296% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Do institutionals and insiders hold more shares of UTRS or MOTS? 20.1% of Motus GI shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by company insiders. Comparatively, 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, UTRS or MOTS? Motus GI has lower revenue, but higher earnings than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMinerva Surgical$51.69M0.00-$34.11M-$8.21N/AMotus GI$319K0.00-$12.87M-$15.640.00 Does the media favor UTRS or MOTS? In the previous week, Minerva Surgical had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Motus GI. Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score. Company Overall Sentiment Minerva Surgical Neutral Motus GI Neutral SummaryMinerva Surgical beats Motus GI on 8 of the 13 factors compared between the two stocks. Ad Stansberry ResearchRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years. Click here for all the details. Get Minerva Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTRS vs. The Competition Export to ExcelMetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio0.0025.3790.1317.18Price / SalesN/A45.881,116.34117.09Price / CashN/A43.4043.1037.85Price / BookN/A7.094.784.78Net Income-$34.11M$13.64M$120.31M$225.60M Minerva Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00174News CoverageMOTSMotus GIN/A$0.00flatN/A-100.0%$1,000.00$319,000.000.0030Gap DownNYXHNyxoah1.7624 of 5 stars$8.00flat$17.00+112.5%+74.1%$0.00$4.70M0.00146STVNStevanato Group0.9543 of 5 stars€23.33+0.1%N/A-24.6%$0.00$1.17B49.435,635SYKStryker4.954 of 5 stars$372.70-0.5%$404.35+8.5%+23.2%$142.08B$21.97B40.1852,000Analyst ForecastBSXBoston Scientific4.252 of 5 stars$90.46+0.4%$95.52+5.6%+59.9%$133.32B$15.91B75.0248,000Analyst ForecastMMM3M4.7329 of 5 stars$129.47-0.3%$144.87+11.9%+22.5%$70.50B$32.64B16.4085,000Positive NewsBDXBecton, Dickinson and Company4.8872 of 5 stars$227.56+0.9%$283.50+24.6%-6.3%$65.79B$20.18B37.9774,000Analyst DowngradeInsider TradeAnalyst RevisionHigh Trading VolumeRMDResMed4.5266 of 5 stars$241.02+1.0%$227.91-5.4%+35.7%$35.38B$4.81B31.599,980Positive NewsDXCMDexCom4.9184 of 5 stars$76.41-1.0%$98.00+28.3%-34.8%$29.85B$3.95B46.229,600WSTWest Pharmaceutical Services4.9644 of 5 stars$330.57+0.2%$437.75+32.4%-6.3%$23.94B$2.95B48.9710,600 Related Companies and Tools Related Companies Motus GI Alternatives Nyxoah Alternatives Stevanato Group Alternatives Stryker Alternatives Boston Scientific Alternatives 3M Alternatives Becton, Dickinson and Company Alternatives ResMed Alternatives DexCom Alternatives West Pharmaceutical Services Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UTRS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTRS Stock Alerts